Clinical paper on TOOsonix treatment receives top rating among 25 million papers published by Wiley & Sons Inc.

Altmetric, a scoring algorithm used measure of the quality and quantity of online attention among more than 25 million publications made by Wiley & Sons Inc. The algorithm has tracked mor than 25 million research outputs across all sources so far. Compared to these our paper on TOOsonix treatment of AK, BCC and Kaposi Sarcoma has done particularly well and is in the 98th percentile: it’s in the top 5% of all research outputs ever tracked by Altmetric.

See the paper here.

See the Altmetric Attention Score here.